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Your recent report of a pregnancy-related late recrudes-
cence of Plasmodium falciparum malaria in a Ghanaian
woman,1 four years after her last visit to a parasite trans-
mission area, may constitute an illustrative example of
how naturally acquired immunity to this parasite works.
Individuals growing up in areas with continuous trans-
mission of P. falciparum parasites — such as Ghana —
develop substantial clinical immunity to malaria during
childhood, and clinical episodes are an exception in adults
(reviewed in Hviid2). However, low-grade and asympto-
matic parasitemia is probably present in a large proportion
of adults, where it can be maintained for extended periods
in the absence of infection — the evidence suggests several
years. Importantly, such infections, which are controlled at
very low levels by immunity, seem to be important for the
maintenance of clinical protection.3 The woman in the
report by Giobbia and colleagues1 probably carried such
an asymptomatic infection when she arrived in Italy. If this
hypothesis is correct, why did she become ill from her
previously silent infection only when she became pregnant?
The authors suggest pregnancy-associated immunosuppres-
sion. The fact that previously immune women become
highly susceptible to P. falciparum malaria when becoming
pregnant makes this explanation seem plausible. Never-
theless, it is almost certainly incorrect. In endemic areas,
pregnancy-related P. falciparum malaria is concentrated
among primigravidae, and susceptibility rapidly decreases
with increasing parity. The immunosuppression hypothesis
cannot adequately explain this. Instead, it now seems evident
that the placenta creates opportunities for P. falciparum
infection not available in non-pregnant hosts.4 Furthermore,
placenta-dwelling parasites express antigens on the infected
erythrocyte surface that are distinct from those expressed
by other P. falciparum, and these antigens are major targets
of acquired protective immunity to pregnancy-associated
malaria.5—7 Because the antigens expressed by placental
parasites are distinct, a woman is completely susceptible to
such an infection when she becomes pregnant for the
first time, even if her pre-existing acquired immunity can
control non-placental parasitemia at low levels (reviewed in
Hviid8). The parasites can switch between different surface
antigens and therefore no new infection is needed to initiate
placental infection in an individual parasitemic at the time
of pregnancy.9,10
Apart from providing an exciting piece of evidence
in favor of this hypothesis, the report by Giobbia et al.1
suggests that physicians should consider the risk of preg-
nancy-associated malaria in women who have grown up in
endemic areas, even if they have not visited such areas for
long periods prior to pregnancy.Conflict of interest: No conflict of interest to declare.
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